close

Novasep and PharmaZell become one group

Novasep, a major CDMO focused on complex small molecules and antibody-drug conjugates (ADCs), and PharmaZell, a leading supplier of highly resilient and specialty APIs, have just closed their merger, following exclusive negotiations initiated in September 2021. This strategic merger creates a technology driven, leading Franco-German CDMO and API manufacturer. Novasep’s…..

Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a Potential Treatment Against Recurrent C. difficile Infection

Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a Potential Treatment Against Recurrent C. difficile Infection SER-109 has the potential to be the first-ever live biotherapeutic product (LBP) to be produced commercially; the collaboration with Seres Therapeutics is a critical milestone for Bacthera, a joint venture between a…..

GTP Bioways is acquiring IDBiotech and invests €12M in two GMP biopharmaceutical production units

GTP Bioways is acquiring IDBiotech and invests €12M in two GMP biopharmaceutical production units   Acquisition of CRO IDBiotech GTP Bioways, a French CDMO (Contract Development and Manufacturing Organization) specializing in the production of biotherapies and nanotherapies,  has acquired IDBiotech. Based in Issoire (France), this CRO  specialises in the development…..

Clean Biologics is acquiring Biodextris

Clean Biologics is acquiring Biodextris  Clean Biologics, a French group providing services to the biopharmaceutical industry,  is acquiring Biodextris, a Contract Development and Manufacturing Organization (CDMO) based in Laval (Montreal), Canada. Biodextris provides analytical and process development, early-phase clinical manufacturing and quality control testing services for clients in the vaccine…..

Minaris Regenerative Medicine will produce Mustang Bio’s MB107 lentiviral gene therapy for the treatment of SCID

 Minaris Regenerative Medicine will produce Mustang Bio's MB107 lentiviral gene therapy for the treatment of SCID Mustang Bio, a US clinical-stage biopharmaceutical company focused on cell and gene therapies for the treatment of hematologic cancers, solid tumors and rare genetic diseases, and Minaris Regenerative Medicine, a leading global contract development…..